Basit öğe kaydını göster

dc.contributor.authorGuvenir, Hakan
dc.contributor.authorDibek Mısırlıoğlu, Emine
dc.contributor.authorVezir, Emine
dc.contributor.authorToyran, Müge
dc.contributor.authorGinis, Tayfur
dc.contributor.authorCivelek, Ersoy
dc.contributor.authorKocabaş, Can Naci
dc.date.accessioned2020-11-20T15:04:57Z
dc.date.available2020-11-20T15:04:57Z
dc.date.issued2015
dc.identifier.issn1088-5412
dc.identifier.issn1539-6304
dc.identifier.urihttps://doi.org/10.2500/aap.2015.36.3858
dc.identifier.urihttps://hdl.handle.net/20.500.12809/2951
dc.descriptionWOS: 000361081000009en_US
dc.descriptionPubMed ID: 26314820en_US
dc.description.abstractBackground: Nonsteroidal anti-inflammatory drugs (NSAID) are the second-most frequent drugs that cause hypersensitivity reactions among children. Studies related to NSAIDs hypersensitivity in children are limited. In this study, we aimed to evaluate children admitted with suspicion of NSAIDs reaction. Method: Between January 1, 2011, and November 30, 2014, we included patients with suspicion of NSAIDs hypersensitivity in our clinic. For evaluation, skin tests and oral provocation tests with the drug (suspected or alternative) were proposed. Reactions were classified and defined according to the latest European Academy of Allergy and Clinical Immunology position paper on NSAID hypersensitivity. Results: During the study period, 123 patients (with 136 drug reactions) were admitted to our clinic with suspected NSAID hypersensitivity. The mean (standard deviation) age of the patients, 67 female (55%), was 83.10 +/- 56.05 months. Thirteen patients described reactions to more than one chemically unrelated NSAID, and 110 patients described reactions with chemically similar drugs. Eight patients were not included because they did not have provocation tests. Thus, 115 patients were evaluated. A hundred and thirty provocations were performed. Twenty patients (17.4%) were diagnosed with NSAID hypersensitivity (13 patients diagnosed by provocation tests and 7 patients diagnosed according to their history). The most frequently encountered agent was ibuprofen (50% [10/20]). Eighty percent (16 patients) of the reactions were considered "non-cross-reactive type." Fifteen patients (75%) were classified as having single-NSAID-induced urticaria and/or angioedema, three patients were classified as having NSAID-induced urticaria and/or angioedema, one patient was classified as having NSAID-exacerbated respiratory disease, and the other patients were classified as having single-NSAID-induced delayed hypersensitivity reactions. Conclusion: Detailed history and drug provocation tests are important to verify NSAID hypersensitivity. The most common type is the non cross-reactive type, and, in our study, the most common responsible drug was ibuprofen.en_US
dc.item-language.isoengen_US
dc.publisherOcean Side Publications Incen_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChildrenen_US
dc.titleNonsteroidal anti-inflammatory drug hypersensitivity among childrenen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorKocabaş, Can Naci
dc.identifier.doi10.2500/aap.2015.36.3858
dc.identifier.volume36en_US
dc.identifier.issue5en_US
dc.identifier.startpage386en_US
dc.identifier.endpage393en_US
dc.relation.journalAllergy and Asthma Proceedingsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster